Patents by Inventor María Martha PEDRAZA ESCALONA

María Martha PEDRAZA ESCALONA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies against the DEC-205 receptor of chicken dendritic cells
    Patent number: 9951135
    Abstract: The invention relates to the production and the characterization of new murine monoclonal antibodies that recognize the domain CTDL-2 (SEQ ID NO: 1) of the cell receptor DEC-205 of dendritic cells in chickens (Gallus gallus), pigs, (Sus scrofa) and humans (Homo sapiens). The invention also relates to the capacity of the new antibodies to direct and modulate the immune response at different levels in chickens (Gallus gallus) and pigs (Sus scrofa), as well as recognizing the receptor DEC-205 in dentritic cells and cell lines in humans. In addition, the invention is used to quickly produce a specific humoral immune response against Hemaglutinina H5 of the H5N2-type avian flu virus.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: April 24, 2018
    Assignee: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
    Inventors: Lourival Domingos Possani Postay, María Martha Pedraza Escalona, Gerardo Pavel Espino Solis, Alejandro Olvera Rodríguez, Héctor Miguel Cardoso Torres
  • NEW MONOCLONAL ANTIBODIES AGAINST THE RECEPTOR DEC-205 OF CHICKEN DENTRITIC CELLS
    Publication number: 20160347841
    Abstract: The invention relates to the production and the characterisation of new murine monoclonal antibodies that recognize the domain CTD-2 (SEQ ID NO: 1) of the cell receptor DEC-205 of dendritic cells in chickens (Gallus gallus), pigs, (Sus scrofa) and humans (Homo sapiens). The invention also relates to the capacity of the new antibodies to direct and modulate the immune response at different levels in chickens (Gallus gallus) and pigs (Sus scrofa), as well as recognising the receptor DEC-205 in dentritic cells and cell lines in humans, In addition, the invention is used to quickly produce a specific humoral immune response against Hemaglutinina H5 of the H5N2-type avian flu virus.
    Type: Application
    Filed: June 17, 2014
    Publication date: December 1, 2016
    Applicant: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
    Inventors: Lourival Domingos POSSANI POSTAY, María Martha PEDRAZA ESCALONA, Gerardo Pavel ESPINO SOLIS, Alejandro OLVERA RODRÍGUEZ, Héctor Miguel CARDOSO TORRES